Policy Shifts and the Topsy-Turvy World of Pediatric Asthma Management The recent withdrawal of a leading asthma inhaler for children has sparked a host of debates among healthcare professionals, families, and policy makers. At its core, this story is about how Medicaid policy changes, particularly those affecting drug rebate caps, have led to unforeseen complications […] More